The Vitreoretinal Surgery Devices market accounted for USD 2.32 Billion in 2024 and is expected to reach USD 4.01 Billion by 2035, growing at a CAGR of around 5.1% between 2025 and 2035. The market is the medical devices used in vitreoretinal surgery wherein procedures are performed to treat disorders of the retina, vitreous body, and macula including diabetic retinopathy, age-related macular degeneration, retinal detachment, and epiretinal membranes.
Reese Park
Kaspersen Davenport
True Hogan
Pk44
Maureen West Law
Gauthier Marsh
Mattingly Jorgensen
Vind Gissel
Hessellund Yildirim
Kamper Hendriksen